Non-IgM Monoclonal Gammopathy of Undetermined Significance
2 clinical trials · Condition
◉ Watch Non-IgM Monoclonal Gammopathy of Undetermined Significance
| Record | Firm | Date |
|---|---|---|
| Rifaximin Versus No Intervention for the Treatment of IgG/IgA (Non-IgM) Monoclonal Gammopathy of Undetermined Significance (NCT07209371) | Fred Hutchinson Cancer Center | 2026-01-22 |
| A Study of Carbon 13-based Deep Labelling of Bone Marrow Cells (NCT07057583) | Mayo Clinic | 2025-02-01 |
Track Non-IgM Monoclonal Gammopathy of Undetermined Significance automatically
Every clearance here is in the API, with alerts when new ones post.